Urinary Assessment among Nigerians in Health and with Frequent Use of Non-steroidal Anti-inflammatory Drugs

Authors

  • P. K. Uduagbamen
  • M. A. Hamzat
  • O. Ehioghae

Keywords:

non-steroidal anti-inflammatory drugs, albumin creatinine ratio, protein creatinine ratio, 24-hour urine protein, glomerular filtration rate

Abstract

Background: Proteinuria is a risk factor for the occurrence and progression of chronic kidney disease hence its use in screening, diagnosis and monitoring purposes. The use of untimed sample has become more common due to shortcomings associated with 24 hour urine collection.

Aim: To use urinary measures in comparing the kidney function of a healthy population with an apparently healthy population with frequent use of non-steroidal anti-inflammatory drugs (NSAIDs).

Methods: Two hundred participants submitted paired urine samples. Blood was collected for estimation of creatinine based glomerular filtration rate (GFR). Student t-test and Chi-square tests were used to compare means and proportions respectively.

Result: The prevalence of kidney dysfunction among NSAIDs users using eGFR, albumin creatinine ratio (ACR), protein creatinine ratio (PCR) and 24 hour urine protein (24HUP) were 22%, 18%, 16% and 11% while in the controls were 6%, 6%, 5% and 0% respectively. The albumin creatinine ratio (ACR) was most strongly correlated with GFR in NSAIDs users.

Conclusion: The prevalence of kidney dysfunction using eGFR, ACR, PCR and 24HUP in NSAIDs users were all higher than in the healthy controls. The correlation between GFR and ACR was strongest of all urinary measures hence the ACR was a more reliable measure of kidney function assessment in health and in frequent NSAIDs use.

References

Hillege HL, Fidler V, Diercks GFH, van Gilst WH, de Castro AF, Feldman HI, et al. CKD-EPI (Chronic Zeeuw, van Veldhuisen.et al. Urinary albumin Kidney Disease Epidemiology Collaboration) A new excretion predicts cardiovascular and non- equation to estimate glomerular filtration rate. Ann cardiovascular mortality in general population. Intern Med. 2009; 150(9): 604–612

Circulation. 2002; 106(14): 1777-82. 14. Paulose-Ram R, Hirsch R, Dillon C, Gu Q. Frequent

Huan L, Yuezhong L, Chao W, Tao TH. The urine Monthly Use of Selected Non-Prescription and albumin-to-creatinine ratio is a reliable indicator for Prescription Non-Narcotic Analgesics Among U.S. evaluating complications of chronic kidney disease Adults. Pharmacolepidemiol Drug Saf 2005; 14(4):

and progression in IgA nephropathy in China Clinics 257-66

; 7(5): 243-250 15. Martínez S,Aguilo A, Moreno C, Lozano L, Tauler P.

Medina-Rosas J, Gladman DD, Su J, Sabapathy A, Use of Non-Steroidal Anti-Inflammatory Drugs Urowitz MB, Touma Z. Utility of untimed single among Participants in a Mountain Ultramarathon urine protein/creatinine ratio as a substitute for 24-h Event. Sports (Basel).2017; 5, 11 proteinuria for assessment of proteinuria in systemic 16. Haque N, Debnath BC, Ibrahim M, Sirajuddin K, lupus erythematosus. Arthritis Research & Therapy. Majumder M, Hossain M S. Association of HbA1c

; 17: 296. with Urinary ACR and eGFR in type-2 diabetes

Arogundade F, Abubakr S, Muzamil H, Aderoju G, mellitus. Pulse. 2011; 5, 1.

Funmilayo O et al. Undiagnosed hypertension and 17. Bakris GL, Molitch M. Microalbuminuria as a Risk proteinuria in a market population in Ile-Ife, Nigeria. Predictor in Diabetes: The Continuing Saga. Diabetes Arab J Nephrol Transpl. 2011; 4(3): 141-146 Care 2014; 37(3): 867–875.

Alebiosu OC. Clinical Diabetic Nephropathy in a 18. Lamb EJ, MacKenzie E, Stevens PE. How should Tropical African Population West Afr J Med 2003; proteinuria be detected and measured? Ann Clin

(2): 152-5 Biochem 2009; 46: 205-217

Brenyah RC, Ephraim RKD, Owiredu WKBA, 19. Kidney Disease: Improving Global Outcomes Eghan BA, Quaye L. Prevalence and determinants of (KDIGO) 2012: Clinical practice guideline for the proteinuria among type 2 diabetics in Kumasi, evaluation and management of chronic kidney Ghana. J Med Biomed Sci 2013; 2:1 disease. Kidney Int 2013; 3(1): 1–150

Chen CF, Yang WC, Yang CY, Li SY, Ou SM, Chen 20. Chronic Kidney Disease (Partial Update): Early YT et al. Urinary protein/creatinine ratio weighted by identification and management of chronic kidney estimated urinary creatinine improves the accuracy disease in adults in primary and secondary care. of predicting daily proteinuria. Am J Med Sci 2015; Clinical Guideline 182 Methods, evidence and

(6): 477-87 recommendations. National Institute for Health and

Evidence-based Clinical Practice Guideline for CKD Care Excellence, 2014. Assessed 24th June 2016

Clin Exp Nephrol 2014; 18, 346-423 21. Weaver RG, James MT, Ravani P, Weaver CGW,

National Kidney Foundation. K/DOQI Clinical Lamb EJ, Tonelli M et al. Estimating Urine AlbuminPractice Guidelines for Chronic Kidney Disease: to-Creatinine Ratio From Protein-to-Creatinine evaluation, classification, and stratification. Am J Ratio: Development of Equations Using Same-Day Kidney Dis. 2002; 39(suppl 1):S1–S266 Measurements. J Am Soc Nephrol 2020 31(3): 591-

Schwarz A, Krause PH, Kunzendorf U, Keller F, 601.

Distler A. The outcome of acute interestial nephritis: 22. Ogasawara S, Hosojima M, Kaseda R, Kabasawa H, risk factors for the transition from acute to chronic Yamamoto-Kabasawa K, Kurosawa H, et al. interstistial nephritis. Clin Nephrol 2000; 54(3): 179- Significance of urinary full-length and ectodomain

forms of megalin in patients with type 2 diabetes.

Weir MR. Renal effects of nonselective NSAIDs and Diabetes Care. 2012; 35(5): 1112–8.

coxibs. Cleve Clin J Med. 2002; 69(Suppl 1):SI53-8 23. Thakur SK, Dhakal SP, Parajuli S, Sah AK, Nepal SP,

Jayasinghe K. White SM, Kerr PG, MacGregor D, Paudel BD. Microalbuminuria and Its Risk Factors in

Stark Z, Wilkins E et al. Isolated proteinuria due to Type 2 Diabetic Patients. J Nepal Health Res Counc

CUBN homozygous mutation – challenging the 2019; 17(1): 61-65 investigative paradigm. BMC Nephrology 2019; 20: 24. De Broe ME, Elseviers MM. Over-the-Counter

Analgesic Use JASN 2009, 20 (10) 2098-2103.

Nicolson TJ, Mellor HR, Roberts RRA. Gender disease. Hidden consequences of the epidemic. Afr J

differences in drug toxicity. Trends Pharmacol Sci. Prim Health Care Fam Med 2017; 9(1): 1435

; 31(3): 108–114 29. Horl WH. Nonsteroidal Anti-Inflammatory Drugs

Corsini A, Bortolini M. Drug-Induced Liver Injury: and the Kidney. (Pharmaceuticals Basel) 2010; 3(7):

The Role of Drug Metabolism and Transport. J Clin 2291-2321.

Pharmacol 2013; 53(5): 463-474 30. Han JS, Lee MJ, Park KS, Han SH, Yoo TH, Oh KH et

Amira CO, Sokunbi DO, Dolapo D, Sokunbi A. al. Albuminuria as a Risk Factor for Anemia in

Prevalence of obesity, overweight and proteinuria in Chronic Kidney Disease: Result from the KoreaN

an urban community in South West Nigeria. Niger Cohort Study for Outcomes in Patients With Chronic

Med J 2011; 52: 110-113 Kidney Disease (KNOW-CKD) Plus ONE 2015;

Kovesty CP, Furth SL, Zoccali C. Obesity and kidney 10(10): e0139747.

Downloads

Published

2023-10-08

How to Cite

Uduagbamen, P. K., Hamzat , M. A., & Ehioghae , O. (2023). Urinary Assessment among Nigerians in Health and with Frequent Use of Non-steroidal Anti-inflammatory Drugs. Research Journal of Health Sciences, 8(4), 225–223. Retrieved from https://rjhs.org/index.php/home/article/view/255